Woodcock Rebuffs Proposed ‘Firewall’ Between FDA Staff Following Aducanumab Dispute

Acting FDA Commissioner Janet Woodcock rejected a proposal to put up a “firewall” between FDA staff involved in pre-submission interactions and staff working on post-submission drug and biologic reviews and decisions, defending the agency’s collaboration with sponsors as critical to the development process.
Source: Drug Industry Daily